{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T18:57:10Z","timestamp":1785869830637,"version":"3.56.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.intimp.2019.105959","type":"journal-article","created":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T05:00:33Z","timestamp":1571547633000},"page":"105959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Key role of organic cation transporter 2 for the nephrotoxicity effect of triptolide in rheumatoid arthritis"],"prefix":"10.1016","volume":"77","author":[{"given":"Qingqing","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqiao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengqiu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.105959_b0005","doi-asserted-by":"crossref","first-page":"1567463","DOI":"10.1155\/2018\/1567463","article-title":"A systematic review about the efficacy and safety of Tripterygium wilfordii Hook.f. preparations used for the management of rheumatoid arthritis","volume":"2018","author":"Wang","year":"2018","journal-title":"Evid. Based. Compl. Alternat. Med."},{"key":"10.1016\/j.intimp.2019.105959_b0010","unstructured":"China Food and Drug Administration. http:\/\/samr.cfda.gov.cn\/WS01\/CL1989\/70473.html (accessed 01 April 2012)."},{"key":"10.1016\/j.intimp.2019.105959_b0015","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fphar.2016.00402","article-title":"Safety profiles of Tripterygium wilfordii Hook F: a systematic review and meta-analysis","volume":"7","author":"Zhang","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105959_b0020","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jep.2015.01.004","article-title":"Investigation of the active components in Tripterygium wilfordii leading to its acute hepatotoxicty and nephrotoxicity","volume":"162","author":"Li","year":"2015","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2019.105959_b0025","first-page":"125","article-title":"Clinical application, untoward reaction and its prevention of TWP","volume":"2","author":"Huang","year":"2005","journal-title":"Drug. Eval."},{"issue":"2","key":"10.1016\/j.intimp.2019.105959_b0030","first-page":"165","article-title":"Pathological study on autopsy died of Tripterygium intoxication\u2014\u2014report of 4 cases","volume":"29","author":"Huang","year":"2009","journal-title":"Chin. J. Integr. Trad. West. Med."},{"issue":"3","key":"10.1016\/j.intimp.2019.105959_b0035","first-page":"214","article-title":"The influence of triptolide sub-chronic intoxication on kidney and testicle in mice","volume":"30","author":"Liu","year":"2001","journal-title":"Acta Med. Universitatis. Scientiae. et Technologiae. Huazhong."},{"issue":"3","key":"10.1016\/j.intimp.2019.105959_b0040","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11596-011-0377-4","article-title":"Role of reactive oxygen species in triptolide-induced apoptosis of renal tubular cells and renal injury in rats","volume":"31","author":"Yang","year":"2011","journal-title":"J. Huazhong Univ. Sci. Technolog. Med. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2019.105959_b0045","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.toxlet.2013.08.014","article-title":"Triptolide alters barrier function in renal proximal tubular cells in rats","volume":"223","author":"Sun","year":"2013","journal-title":"Toxicol. Lett."},{"issue":"4","key":"10.1016\/j.intimp.2019.105959_b0050","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tiv.2009.01.021","article-title":"Caspase 3 is involved in the apoptosis induced by triptolide in HK-2 cells","volume":"23","author":"Shu","year":"2009","journal-title":"Toxicol. In Vitro."},{"issue":"3","key":"10.1016\/j.intimp.2019.105959_b0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1091581809337418","article-title":"Heat shock protein 72 protects kidney proximal tubule cells from injury induced by triptolide by means of activation of the MEK\/ERK pathway","volume":"28","author":"Wang","year":"2009","journal-title":"Int. J. Toxicol."},{"issue":"2","key":"10.1016\/j.intimp.2019.105959_b0060","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.toxlet.2012.07.008","article-title":"Role of Nrf2 in protection against triptolide-induced toxicity in rat kidney cells","volume":"213","author":"Li","year":"2012","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.intimp.2019.105959_b0065","first-page":"010409","article-title":"G Global Health Epidemiology Reference, Prevalence of rheumatoid arthritis in low- and middle-income countries: a systematic review and analysis","volume":"5","author":"Rudan","year":"2015","journal-title":"J Glob Health"},{"issue":"2","key":"10.1016\/j.intimp.2019.105959_b0070","first-page":"355","article-title":"Myopenia is associated with joint damage in rheumatoid arthritis: a cross-sectional study","volume":"10","author":"Lin","year":"2019","journal-title":"J. Cach. Sarcop. Musc."},{"issue":"12","key":"10.1016\/j.intimp.2019.105959_b0075","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/jat.2979","article-title":"Lipopolysaccharide exposure augments isoniazide-induced liver injury","volume":"34","author":"Su","year":"2014","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.intimp.2019.105959_b0080","doi-asserted-by":"crossref","DOI":"10.1177\/2058738418772210","article-title":"Xanthine oxidase inhibitors and sepsis","volume":"32","author":"Ramos","year":"2018","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105959_b0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.tox.2019.01.005","article-title":"A new perspective of triptolide-associated hepatotoxicity: liver hypersensitivity upon LPS stimulation","volume":"414","author":"Yuan","year":"2019","journal-title":"Toxicology"},{"issue":"7","key":"10.1016\/j.intimp.2019.105959_b0090","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/0192623316656416","article-title":"Regulatory forum opinion piece: review of FDA draft guidance testicular toxicity-evaluation during drug development guidance for industry","volume":"44","author":"Hukkanen","year":"2016","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.intimp.2019.105959_b0095","unstructured":"FDA. U.S. FDA Guidance for Industry (Draft): Drug Interaction Studies \u2013 Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations [A\/OL]. http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm064982.htm (accessed 09 March 2017)."},{"issue":"1","key":"10.1016\/j.intimp.2019.105959_b0100","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1124\/jpet.106.113076","article-title":"Characterization of the uptake of organic anion transporter (OAT) 1 and OAT3 substrates by human kidney slices","volume":"321","author":"Nozaki","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Suppl 7","key":"10.1016\/j.intimp.2019.105959_b0105","first-page":"S110","article-title":"Evaluation and quantitative prediction of renal transporter-mediated drug-drug interactions","volume":"56","author":"Feng","year":"2016","journal-title":"J. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2019.105959_b0110","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/jphp.12994","article-title":"Pharmacokinetic changes of cefdinir and cefditoren and its molecular mechanisms in acute kidney injury in rats","volume":"70","author":"Wang","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105959_b0115","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.biopha.2018.07.068","article-title":"Involvement of organic cation transporter 2 in the metformin-associated increased lactate levels caused by contrast-induced nephropathy","volume":"106","author":"Yang","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.intimp.2019.105959_b0120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1124\/dmd.108.023630","article-title":"Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6","volume":"37","author":"Le Vee","year":"2009","journal-title":"Drug. Metab. Dispos."},{"issue":"1s","key":"10.1016\/j.intimp.2019.105959_b0125","doi-asserted-by":"crossref","first-page":"325s","DOI":"10.18433\/jpps30241","article-title":"STAT3 is involved in IL-6-mediated downregulation of hepatic transporters in mice","volume":"21","author":"Abualsunun","year":"2018","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2019.105959_b0130","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bcp.2011.04.017","article-title":"Regulation of drug transporter expression by oncostatin M in human hepatocytes","volume":"82","author":"Le Vee","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"01","key":"10.1016\/j.intimp.2019.105959_b0135","first-page":"15","article-title":"LC-MS quantification of triptolide and its transport across the caco-2 cell monolayer","volume":"24","author":"Sun","year":"2016","journal-title":"Pharmaceut. Clin. Res."},{"key":"10.1016\/j.intimp.2019.105959_b0140","first-page":"1","article-title":"Study on difference of liver toxicity and its molecular mechanisms caused by Tripterygium wilfordii multiglycoside and equivalent amount of triptolide in rats","author":"Miao","year":"2019","journal-title":"Chin. J. Chin. Mater. Med."},{"key":"10.1016\/j.intimp.2019.105959_b0145","doi-asserted-by":"crossref","first-page":"11747","DOI":"10.1038\/srep11747","article-title":"Inhibition of P-glycoprotein gene expression and function enhances triptolide-induced hepatotoxicity in mice","volume":"5","author":"Kong","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2019.105959_b0150","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.intimp.2018.04.017","article-title":"Rutin and rutin-conjugated gold nanoparticles ameliorate collagen-induced arthritis in rats through inhibition of NF-kappaB and iNOS activation","volume":"59","author":"Gul","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2019.105959_b0155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tox.2018.06.010","article-title":"In vivo exposure to hydroquinone during the early phase of collagen-induced arthritis aggravates the disease","volume":"408","author":"Heluany","year":"2018","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.intimp.2019.105959_b0160","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1124\/dmd.107.016907","article-title":"Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta","volume":"36","author":"Le Vee","year":"2008","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.intimp.2019.105959_b0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.taap.2017.04.013","article-title":"Targeting Oct2 and P53: formononetin prevents cisplatin-induced acute kidney injury","volume":"326","author":"Huang","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2019.105959_b0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/bdd.2112","article-title":"Renal vectorial transport of berberine mediated by organic cation transporter 2 (OCT2) and multidrug and toxin extrusion proteins 1 (MATE1) in rats","volume":"39","author":"Shi","year":"2018","journal-title":"Biopharm. Drug Dispos."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2019.105959_b0175","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2017.12.037","article-title":"OAT1 and OAT3 also mediate the drug-drug interaction between piperacillin and tazobactam","volume":"537","author":"Wen","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.intimp.2019.105959_b0180","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jep.2014.01.026","article-title":"Glycyrrhizin accelerates the metabolism of triptolide through induction of CYP3A in rats","volume":"152","author":"Tai","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2019.105959_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fct.2017.09.051","article-title":"Early indications of ANIT-induced cholestatic liver injury: Alteration of hepatocyte polarization and bile acid homeostasis","volume":"110","author":"Yang","year":"2017","journal-title":"Food. Chem. Toxicol."},{"issue":"3","key":"10.1016\/j.intimp.2019.105959_b0190","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/bdd.653","article-title":"Transport characteristics of L-citrulline in renal apical membrane of proximal tubular cells","volume":"30","author":"Mitsuoka","year":"2009","journal-title":"Biopharm. Drug. Dispos."},{"issue":"4","key":"10.1016\/j.intimp.2019.105959_b0195","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1371\/journal.pone.0000385","article-title":"Identification of the endogenous key substrates of the human organic cation transporter OCT2 and their implication in function of dopaminergic neurons","volume":"2","author":"Taubert","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2019.105959_b0200","doi-asserted-by":"crossref","first-page":"385352","DOI":"10.1155\/2014\/385352","article-title":"TNFalpha promotes Th17 cell differentiation through IL-6 and IL-1beta produced by monocytes in rheumatoid arthritis","volume":"2014","author":"Zheng","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.intimp.2019.105959_b0205","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.intimp.2017.05.028","article-title":"Anti-inflammatory effects of ursolic acid-3-acetate on human synovial fibroblasts and a murine model of rheumatoid arthritis","volume":"49","author":"Lee","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2019.105959_b0210","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/ndt\/17.6.1005","article-title":"Elevation of serum and urine levels of TIMP-1 and tenascin in patients with renal disease","volume":"17","author":"Horstrup","year":"2002","journal-title":"Nephrol. Dial. Transp."},{"key":"10.1016\/j.intimp.2019.105959_b0215","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cca.2013.12.031","article-title":"Novel indicators of fibrosis-related complications in children with chronic kidney disease","volume":"430","author":"Musial","year":"2014","journal-title":"Clin. Chim. Acta."},{"issue":"6","key":"10.1016\/j.intimp.2019.105959_b0220","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1159\/000496001","article-title":"Bioinformatic analyses of renal ischaemia-reperfusion injury models: identification of key genes involved in the development of kidney disease","volume":"43","author":"Zhu","year":"2018","journal-title":"Kidney Blood Press. Res."},{"issue":"5","key":"10.1016\/j.intimp.2019.105959_b0225","first-page":"299","article-title":"Serum matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9\/neutrophil gelatinase-associated lipocalin complex levels in patients with early-stage diabetic nephropathy","volume":"12","author":"Cakirca","year":"2018","journal-title":"Iran. J. Kidney Dis."},{"issue":"8","key":"10.1016\/j.intimp.2019.105959_b0230","doi-asserted-by":"crossref","first-page":"e9964","DOI":"10.1097\/MD.0000000000009964","article-title":"Urinary metalloproteinases and tissue inhibitors of metalloproteinases as potential early biomarkers for renal fibrosis in children with nephrotic syndrome","volume":"97","author":"Bienias","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.intimp.2019.105959_b0235","doi-asserted-by":"crossref","first-page":"622","DOI":"10.12659\/AOT.904283","article-title":"Expression and clinical significance of tissue inhibitor of metalloproteinases-1 (TIMP-1) and a disintegrin and metalloproteinase with thrombospondin type 1 motif 1 (ADAMTS1) in post-kidney-transplant bladder tumors","volume":"22","author":"Xue","year":"2017","journal-title":"Ann. Transp."},{"issue":"3","key":"10.1016\/j.intimp.2019.105959_b0240","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.toxlet.2012.12.015","article-title":"In vitro evaluation of biomarkers for cisplatin-induced nephrotoxicity using HK-2 human kidney epithelial cells","volume":"217","author":"Sohn","year":"2013","journal-title":"Toxicol. Lett."},{"issue":"6","key":"10.1016\/j.intimp.2019.105959_b0245","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1039\/C8TX00095F","article-title":"An in vitro method for nephrotoxicity evaluation using HK-2 human kidney epithelial cells combined with biomarkers of nephrotoxicity","volume":"7","author":"Qiu","year":"2018","journal-title":"Toxicol. Res. (Camb)"},{"issue":"10","key":"10.1016\/j.intimp.2019.105959_b0250","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1248\/bpb.b12-00107","article-title":"Rhein inhibits integrin-linked kinase expression and regulates matrix metalloproteinase-9\/tissue inhibitor of metalloproteinase-1 ratio in high glucose-induced epithelial-mesenchymal transition of renal tubular cell","volume":"35","author":"Peng","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.intimp.2019.105959_b0255","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1741-7015-7-12","article-title":"Sex differences in rheumatoid arthritis: more than meets the eye","volume":"7","author":"van Vollenhoven","year":"2009","journal-title":"BMC Med."},{"issue":"4","key":"10.1016\/j.intimp.2019.105959_b0260","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3892\/etm.2015.2667","article-title":"Phenotypic characterization of type II collagen-induced arthritis in Wistar rats","volume":"10","author":"Song","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2019.105959_b0265","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fphar.2016.00087","article-title":"Sex-related differences of lipid metabolism induced by triptolide: the possible role of the LXRalpha\/SREBP-1 signaling pathway","volume":"7","author":"Jiang","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2019.105959_b0270","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00424-007-0308-1","article-title":"Gender differences in kidney function","volume":"455","author":"Sabolic","year":"2007","journal-title":"Pflugers Arch."},{"issue":"9","key":"10.1016\/j.intimp.2019.105959_b0275","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2174\/138920012803341302","article-title":"Drug disposition in pathophysiological conditions","volume":"13","author":"Gandhi","year":"2012","journal-title":"Curr. Drug. Metab."},{"issue":"4","key":"10.1016\/j.intimp.2019.105959_b0280","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ejps.2012.05.012","article-title":"Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats","volume":"47","author":"Xue","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2019.105959_b0285","first-page":"528","article-title":"Research progress on in vivo pharmacokinetics of triptolide and celastrol","volume":"47","author":"Lin","year":"2016","journal-title":"Chin. Trad. Herb. Drugs."},{"issue":"9","key":"10.1016\/j.intimp.2019.105959_b0290","first-page":"151","article-title":"LC-MS\/MS studies on effect of Glycyrrhiza uralensis on metabolism distribution and excretion of triptolide in rat","volume":"16","author":"Liu","year":"2010","journal-title":"Chin. J. Pharm. Anal."},{"issue":"4","key":"10.1016\/j.intimp.2019.105959_b0295","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/jps.23432","article-title":"Involvement of rat organic cation transporter 2 in the renal uptake of jatrorrhizine","volume":"102","author":"Tan","year":"2013","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2019.105959_b0300","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1208\/s12248-013-9465-7","article-title":"Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney","volume":"15","author":"Motohashi","year":"2013","journal-title":"AAPS J"},{"key":"10.1016\/j.intimp.2019.105959_b0305","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejps.2016.03.020","article-title":"Metformin and cimetidine: physiologically based pharmacokinetic modelling to investigate transporter mediated drug-drug interactions","volume":"88","author":"Burt","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"issue":"16","key":"10.1016\/j.intimp.2019.105959_b0310","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1111\/bph.13537","article-title":"Role of OCT2 and MATE1 in renal disposition and toxicity of nitidine chloride","volume":"173","author":"Li","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2019.105959_b0315","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12906-016-1504-3","article-title":"Triptolide Induces hepatotoxicity via inhibition of CYP450s in Rat liver microsomes","volume":"17","author":"Lu","year":"2017","journal-title":"BMC Compl. Altern. Med."},{"issue":"11","key":"10.1016\/j.intimp.2019.105959_b0320","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1194\/jlr.M500134-JLR200","article-title":"Downregulation of liver X receptor-alpha in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines","volume":"46","author":"Wang","year":"2005","journal-title":"J. Lipid. Res."},{"issue":"11","key":"10.1016\/j.intimp.2019.105959_b0325","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00424-017-2033-8","article-title":"Activation of liver X receptor inhibits OCT2-mediated organic cation transport in renal proximal tubular cells","volume":"469","author":"Wongwan","year":"2017","journal-title":"Pflugers Arch."}],"updated-by":[{"DOI":"10.1016\/j.intimp.2020.106228","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000}}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919314997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919314997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:13:18Z","timestamp":1761585198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919314997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":65,"alternative-id":["S1567576919314997"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.105959","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Key role of organic cation transporter 2 for the nephrotoxicity effect of triptolide in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.105959","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105959"}}